We are live on ! Find out more
IMUX icon

Immunic
IMUX

55 hedge funds and large institutions have $35M invested in Immunic in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,050% more call options, than puts

Call options by funds: $161K | Put options by funds: $14K

7% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 14

0.74% more ownership

Funds ownership: 4.49% → 5.24% (+0.74%)

14% less funds holding

Funds holding: 64 → 55 (-9)

21% less capital invested

Capital invested by funds: $44.1M → $35M (-$9.11M)

64% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 14

Holders
55
Holders Change
-9
Holders Change %
-14.06%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
15
Reduced
14
Closed
14
Calls
$161K
Puts
$14K
Net Calls
+$147K
Net Calls Change
-$985K

Top Buyers

Rank Fund Capital Flow
1
Aberdeen Group
Aberdeen Group
United Kingdom
+$6.6M
2
Morgan Stanley
Morgan Stanley
New York
+$2.81M
3
LCM
Laurion Capital Management
New York
+$1.54M
4
APM
Avidity Partners Management
Texas
+$1.07M
5
GCM
Ghisallo Capital Management
Massachusetts
+$767K

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$1.15M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.04M
3
6CM
683 Capital Management
New York
-$769K
4
Renaissance Technologies
Renaissance Technologies
New York
-$493K
5
Marshall Wace
Marshall Wace
United Kingdom
-$471K
Name Holding Trade Value Shares
Change 		Change in
Stake
Marshall Wace
26
Marshall Wace
United Kingdom
$35K -$471K -51,355 -91%
Creative Planning
27
Creative Planning
Kansas
$24.4K – – –
Bank of New York Mellon
28
Bank of New York Mellon
New York
$21.2K -$1.21K -132 -4%
UOC
29
UBS O'Connor
Illinois
$20.9K -$17.3K -1,887 -39%
Charles Schwab
30
Charles Schwab
California
$17.4K – – –
RMC
31
Ring Mountain Capital
California
$17.4K – – –
MG
32
Marex Group
$15.7K – – –
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$15K +$19.9K +2,165 +43,300%
Dimensional Fund Advisors
34
Dimensional Fund Advisors
Texas
$9.17K -$13.2K -1,437 -52%
BWP
35
Balboa Wealth Partners
Arizona
$8.37K – – –
LFAS
36
Level Four Advisory Services
Texas
$7.52K -$358 -39 -3%
PI
37
PFG Investments
New York
$7.32K – – –
RPGK
38
Retirement Planning Group (Kansas)
Kansas
$7.27K – – –
PAG
39
Private Advisor Group
New Jersey
$6.98K – – –
CGA
40
Crescent Grove Advisors
Illinois
$6.97K – – –
DAS
41
Dynamic Advisor Solutions
Arizona
$6.97K – – –
JP Morgan Chase
42
JP Morgan Chase
New York
$6.08K +$6.83K +744 +586%
Simplex Trading
43
Simplex Trading
Illinois
$6K -$96.8K -10,544 -92%
Carson Wealth (CWM LLC)
44
Carson Wealth (CWM LLC)
Nebraska
$6K – – –
AA
45
Addison Advisors
Vermont
$3.63K – – –
SS
46
SBI Securities
Japan
$2.51K +$18 +2 +0.6%
Raymond James Financial
47
Raymond James Financial
Florida
$1.41K +$1.86K +203 New
TRCT
48
Tower Research Capital (TRC)
New York
$1.4K +$1.84K +201 New
Osaic Holdings
49
Osaic Holdings
Arizona
$1.38K – – –
Northwestern Mutual Wealth Management
50
Northwestern Mutual Wealth Management
Wisconsin
$1.05K – – –
1
2
3

IMUX Hedge Fund Activity: Q2 2025 in Review

55 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q2 2025, worth a combined $35M — down 21% from $44.1M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of IMUX and 5 opened new positions — a net loss of 9 holders — while 14 trimmed existing stakes and 15 added.

The largest buyer was Aberdeen Group, adding an estimated $6.6M. The largest seller was BVF Inc, cutting an estimated $1.15M.

  • 55 institutional investors held Immunic (IMUX) as of Q2 2025, down from 64 in Q1 2025.
  • Funds reported $35M of Immunic stock for Q2 2025, down 21% quarter-over-quarter.
  • 5 funds opened new Immunic positions in Q2 2025 and 14 closed out, a net change of -9 holders.
  • The largest Immunic buyer in Q2 2025 was Aberdeen Group, an estimated $6.6M added.
  • The largest Immunic seller in Q2 2025 was BVF Inc, an estimated $1.15M sold.

Based on aggregated 13F filings for Q2 2025.